Answers are grounded in this paper and cite their sources.
We report in this paper the successful production of stable high-concentration graphene dispersions in low-boiling-point, low-polarity conventional organic solvents (chloroform and THF) by liquid-phase noncovalent exfoliation of graphite assisted with a hyperbranched polyethylene (HBPE) as the stabilizer. In the exfoliation process, HBPE adsorbs onto the surface of exfoliated graphene flakes, providing steric stabilization against their restacking. A systematic investigation on the effects of exfoliation conditions, including the solvent and the amounts of graphite and HBPE, has been conducted. Graphene dispersions with the concentration up to 0.18 mg/mL in chloroform and 0.045 mg/mL in THF have been obtained. It is also demonstrated that the dispersions can be further concentrated by solvent evaporation to give highly concentrated stable dispersions at 3.4 mg/mL. Through their characterizations with transmission electron microscopy, atomic force microscopy, and Raman spectroscopy, the majority of the graphene products is found to be high-quality, defect-free, few-layer graphene flakes with the layer number between 2 and 4 and the lateral dimension in the range of 0.2–0.5 μm. The dispersions can be fabricated into flexible conductive free-standing graphene films and be used to prepare graphene/ethylene copolymer composites through solution blending, which show significant enhancements in both thermal and mechanical properties.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: